Published on in Vol 25 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46721, first published .
Use of Digital Health Technology Among Older Adults With Cancer in the United States: Findings From a National Longitudinal Cohort Study (2015-2021)

Use of Digital Health Technology Among Older Adults With Cancer in the United States: Findings From a National Longitudinal Cohort Study (2015-2021)

Use of Digital Health Technology Among Older Adults With Cancer in the United States: Findings From a National Longitudinal Cohort Study (2015-2021)

Authors of this article:

Weijiao Zhou1 Author Orcid Image ;   Youmin Cho2 Author Orcid Image ;   Shaomei Shang1 Author Orcid Image ;   Yun Jiang3 Author Orcid Image

Original Paper

1School of Nursing, Peking University, Beijing, China

2School of Biomedical Informatics, The University of Texas Health Science Center at Houston, Houston, TX, United States

3School of Nursing, University of Michigan, Ann Arbor, MI, United States

Corresponding Author:

Youmin Cho, PhD, AGPCNP-BC

School of Biomedical Informatics

The University of Texas Health Science Center at Houston

UCT600 E635-3

7000 Fannin St

Houston, TX, 77030

United States

Phone: 1 713 500 3591

Email: youmcho@umich.edu


Background: Despite the benefits of digital health technology use, older adults with cancer (ie, aged 65 years) have reported challenges to technology adoption. However, there has been a lack of a good understanding of their digital health technology use patterns and the associated influential factors in the past few years.

Objective: This study aimed to examine the trends in and factors associated with digital health technology use among older adults with cancer.

Methods: The National Health and Aging Trends Study (NHATS) data set is a national longitudinal cohort study with annual survey waves of Medicare beneficiaries 65 years and older. Participants were community-dwelling older adults who self-reported previous or current cancer diagnoses in each round. The study sample size of each round ranged from 1996 (2015) to 1131 (2021). Digital health technology use was defined as using the internet or online in the last month to order or refill prescriptions, contact medical providers, handle Medicare or other insurance matters, or get information about their health conditions. The association of sociodemographics, clinical factors (self-rated health, chronic conditions, difficulties in activities of daily living, dementia, anxiety, and depression), and physical function (Short Physical Performance Battery and grip strength) with digital health technology use was examined using design-based logistic regression. All statistical analyses accounted for the complex sample design.

Results: The prevalence of any digital health technology use increased from 36% in 2015 to 45% in 2019. In 2020-2021, which was amid the COVID-19 pandemic, it ranged from 51% to 52%. In terms of each digital health technology use behavior, in 2015, overall, 28% of older cancer survivors used digital health technology to obtain health information, followed by contacting clinicians (19%), filling prescriptions (14%), and handling insurance (11%). Greater use of digital health technology was associated with younger age, being White, having a college or higher education, having a higher income, having more comorbidities, nondementia, and having a higher gait speed.

Conclusions: Digital health technology use in older adults with cancer has gradually increased, particularly during the COVID-19 pandemic. However, socioeconomic and racial disparities have remained in older cancer survivors. Additionally, older adults with cancer may have some unique features associated with digital health technology use; for example, their use of digital health may be increased by their comorbidities (ie, health care needs) and reduced by their frailty.

J Med Internet Res 2023;25:e46721

doi:10.2196/46721

Keywords



In 2022, there were over 18 million cancer survivors in the United States, which account for approximately 5% of the entire population [1]. Among those cancer survivors, 67% are currently aged 65 years or older, and it is estimated to increase to 74% by 2040 [1]. During and after cancer treatment, cancer survivors struggle with multiple acute or chronic symptoms related to their treatments or the disease [2]. In recent years, digital health technologies, such as electronic communications with clinicians or telehealth visits, have been increasingly used to facilitate health care delivery. It has been demonstrated that digital health technology use among patients with and survivors of cancer, such as electronic communication with health care providers, reduces their symptom distress and emergency department admissions and improves survival rates [3-6]. Furthermore, patients with and survivors of cancer have experienced improved well-being and better patient satisfaction while using digital health technology [7-10].

A body of literature has pointed out that older adults (aged 65 years or older) have shown a significantly lower use of digital health technology than individuals in other age groups [11-13], which may be because older adults tend to prefer direct in-person relationships with their health care providers, having potential concerns about eroding patient-provider trust and information privacy and security while using digital health technology [12,13]. According to Levine et al’s [14,15] research from 2016 and 2018, the everyday use of technology by older adults, including web-based shopping or banking, was lower than that of the general population. Furthermore, their use of digital health technology was even lower than their use of everyday technology, and this decreased gradually as their health declined [14,15]. Regarding older adults with cancer, previously published literature supports low use of everyday technology [16], but it also reveals a slight increase in use since the COVID-19 pandemic [17]. A secondary analysis of nationally representative survey data in the United States revealed that cancer survivors aged 65 years or older were significantly less likely to use digital health technology to communicate with their providers than younger survivors [18]. Considering the increasing number of older adults with cancer in the United States and their high level of cancer care needs, they can be the potential major users to be benefited from the use of digital health technology [1,13,18]. A few qualitative studies revealed that older adults with cancer possess a positive attitude toward using digital health technology, particularly after experiencing telehealth during the COVID-19 pandemic [19-21]. However, there is a lack of a good understanding of the pattern of digital health technology use among older adults with cancer, as measured quantitatively and longitudinally in the past few years, considering the impact of the COVID-19 pandemic.

Therefore, the aims of this study were to (1) examine the trends in digital health technology use over time and compare the patterns with everyday technology use (from 2015 to 2021) and (2) identify factors associated with digital health technology use among older adults with cancer. Through analyzing the data from the National Health and Aging Trends Study (NHATS), this study was expected to obtain general insights to inform researchers and health care providers to enhance sustainable oncology care delivery to older adults with cancer.


Data Sources and Study Population

The NHATS is a longitudinal cohort study with annual survey waves of Medicare beneficiaries aged 65 years and older living in the community, residential care, and nursing homes [22]. Data had been collected since 2011 (round 1) and replenished in 2015 (round 5). In both rounds 1 and 5, participants were selected through a stratified 3-stage sample design, with oversampling of older persons and Black non-Hispanic individuals [23]. Each round produced an analytical weight that accounted for differential probabilities of selection and nonresponse. In rounds 1-9, the interview was conducted in person, whereas in round 10, the NHATS interview was conducted by telephone because of the COVID-19 pandemic.

We used cohort data from round 5 to round 11. In round 5, a total of 8334 older adults completed the interviews, and these respondents have been annually reinterviewed until 2021 (round 11). The weighted response rate (rounds 5-11) ranged from 73.6% to 96.0%. For each round, we included participants who were community-dwelling and with self-reported cancer diagnosis in that round or prior rounds. The study sample size of each round is shown in Figure 1, ranging from 1996 (round 5) to 1131 (round 11). For the second aim, participants with missing data of sociodemographic, clinical, and physical factors were excluded. A complete case analysis was conducted.

Figure 1. Change in digital health technology use (weighted). Error bars indicate 95% CIs of the weighted percentages. Individuals who had cancer in previous rounds and were newly diagnosed with cancer in each round were included in the analyses.

Ethics Approval

The NHATS was approved by the Johns Hopkins Bloomberg School of Public Health institutional review board. All participants provided informed consent that described the purpose of a nationally representative survey study designed to benefit numerous researchers. This study was exempt from an institutional ethical review because it involved a publicly available, deidentified data set.

Measures

Digital health technology use was measured by 4 items [14,15]. Participants were asked whether they used the internet or went online in the last month to (1) order or refill prescriptions, (2) contact medical providers, (3) handle Medicare or other insurance matters, or (4) get information about their health conditions. Any digital health technology use was coded as “Yes” when any of the above 4 digital health use behaviors was confirmed. Everyday technology use was coded as “Yes” if participants reported using internet or going online for any reason besides email or texting in the last month. In terms of each type of everyday technology use, participants were asked whether they used the internet or went online in the last month to (1) shop for groceries or personal items (yes or no), (2) pay bills or do banking (yes or no), or (3) visit social network sites (yes or no) [14,15].

Sociodemographic characteristics included (1) age (65-69, 70-74, 75-79, 80-84, 85-89, ≥90 years), (2) sex (female or male), (3) race and ethnicity (non-Hispanic White, non-Hispanic Black, Hispanic, or other), (4) marital status (married or partnered, or not), (5) educational level (less than high school, high school graduate, some college, college graduate, or higher), and (6) annual income (<US $15,000; $15,000-$29,999; $30,000-$44,999; $45,000-$60,000; or >$60,000). Clinical factors, mainly related to self-reported clinical diagnoses and health status, included the following: (1) self-rated health, assessed as excellent, very good, good, fair, or poor; (2) number of chronic conditions, assessed by self-reports of the following chronic conditions: heart attack, heart disease, hypertension, arthritis, osteoporosis, diabetes, lung diseases, and stroke, which ranged from 0 to 8; (3) number of difficulties in activities of daily living (ADL), assessed by validated items assessing whether they had difficulty with the following activities: eating, showering, or bathing, using the toilet, getting dressed, getting out of bed, and getting around inside the home, which ranged from 0 to 6 [24]; (4) diagnosis of dementia, which was self-reported as yes or no; (5) anxiety and depression, assessed by the sum score of the 2 items of the Patient Health Questionnaire-2 and 2 items of the Generalized Anxiety Disorder-2 scale [25,26], which generates a total depression and anxiety score ranging from 4 to 16, with a higher score indicating poorer mental health. Physical functions, mainly related to physical abilities measured by objective methods, included (6) physical performance, assessed by Short Physical Performance Battery (SPPB), which included tests of gait speed, chair stands, and balance activities [27] and rated each from 0 to 4 and generated the total SPPB score ranging from 0 to 12, with a higher score indicating better physical performance; and (7) grip strength, measured twice by a dynamometer (using the highest value), scored using quartiles of the NHATS sample distribution [28], which ranged from 0 to 4, with a higher score indicating better grip strength.

Statistical Analysis

Stata SE (version 17.0; StataCorp) was used for statistical analyses. For aim 1, the complex sample design (ie, stratification and primary sampling units) and sampling weights in each round (rounds 5-11) were accounted for in the analyses. The weighed percentage and 95% CIs were calculated to summarize the digital health technology use and everyday technology use in each round. For aim 2, the complex sample design was also accounted for in the analyses. Descriptive statistics (ie, percentages for categorical variables and means and SEs for continuous variables) were calculated to summarize the digital health technology use and sociodemographic, clinical, and physical function factors. Bivariate analyses were used to compare the factors of different groups (ie, none vs any digital health technology use); bivariate differences were assessed with Rao-Scott chi-square tests for categorical variables and design-based F tests for continuous variables. Design-based logistic regression analyses were performed to examine the association between any digital health technology use (yes or no, dependent variable) and (1) sociodemographic factors (model 1); (2) sociodemographic and clinical factors (model 2); and (3) sociodemographic, clinical, and physical function factors (model 3). We conducted analyses using data from round 5 (n=1760) and the recent round 9 (n=1246) and round 11 (n=965). Round 10 was not analyzed because of missing data of physical function–related variables. The adjusted odds ratios (ORs) and 95% CIs were calculated.


Characteristics of Study Population

Table 1 shows the characteristics of the study population collected in 2015. More than 50% of American older adults with cancer were 75 years and older. Most were female (50.2%); non-Hispanic White (88.2%); married or partnered (61.1%); reported excellent, very good, or good health (75.5%); did not obtain college degree (67.4%); and reported comorbidity (81.7%) and no ADL limitation (66.4%). Their average anxiety and depression score was 5.7 (range 4-16), SPPB score was 7.0 (range 0-12), and grip strength score was 2.2 (range 0-4). Individuals who reported any use of digital health technology were more likely to be younger, White, married or partnered, have higher education and income, better self-related health status, less comorbidities, less ADL limitations, lower anxiety and depression score, higher physical performance, and higher grip strength score (P<.001).

Table 1. Characteristics of older adults with cancer by digital health technology use in the United States, 2015 (N=1760).a
CharacteristicOverallDigital health technology useP valueb


None (n=1239)Any (n=521)
Age (years), %c (95% CI)<.001

65-6920.9 (17.9-24.2)15.9 (12.5-20.0)29.4 (24.6-34.8)

70-7426.9 (24.8-29.2)22.7 (20.0-25.6)34.1 (29.9-38.6)

75-7921.6 (19.4-24.0)22.1 (19.2-25.2)20.9 (17.5-24.8)

80-8416.3 (14.5-18.2)20.1 (17.7-22.7)9.8 (7.9-12.3)

85-899.7 (9.6-11.0)12.7 (11.1-14.3)4.7 (3.5-6.4)

≥904.5 (3.7-5.4)6.6 (5.4-8.0)1.0 (0.5-1.9)
Female, % (95% CI)50.2 (47.6-52.9)52.7 (49.8-55.5)46.1 (40.6-52.9).05
Race and ethnicity, % (95% CI)<.001

Non-Hispanic White88.2 (85.9-90.1)84.4 (81.3-87.1)94.5 (92.2-96.2)

Non-Hispanic Black5.0 (4.3-5.9)6.5 (5.4-7.9)2.5 (1.8-3.6)

Hispanic3.7 (2.6-5.2)5.3 (3.7-7.5)0.9 (0.3-2.6)

Other3.1 (2.0-4.7)3.8 (2.5-5.6)2.0 (0.9-4.4)
Married or partnered, % (95% CI)61.1 (58.2-63.9)54.3 (51.0-57.6)72.5 (68.2-76.5)<.001
Education level, % (95% CI)<.001

Less than high school14.5 (12.4-16.8)21.4 (18.7-24.4)2.7 (1.3-5.4)

High school graduate26.2 (23.6-29.1)33.0 (30.0-36.2)14.7 (11.3-18.9)

Some college26.7 (23.9-29.7)25.4 (22.1-28.9)29.0 (24.8-33.5)

College graduate or higher32.6 (28.6-36.9)20.2 (17.2-23.6)53.6 (47.1-60.0)
Annual income (US $), % (95% CI)<.001

<15,00010.5 (9.0-12.3)15.1 (13.0-17.4)2.8 (1.6-4.9)

15,000-29,99920.5 (18.3-23.0)26.8 (23.8-30.0)9.9 (7.5-13.0)

30,000-44,99918.2 (16.3-20.2)19.8 (17.5-22.3)15.5 (11.9-20.0)

45,000-60,00012.1 (10.3-14.0)11.5 (9.2-14.3)13.0 (9.7-17.1)

>60,00038.7 (34.6-42.9)26.8 (22.8-31.1)58.9 (52.6-64.8)
Self-rated health, % (95% CI)<.001

Excellent12.3 (10.3-14.6)9.4 (7.8-11.4)17.2 (13.0-22.3)

Very good28.8 (26.2-31.5)24.3 (21.5-27.3)36.3 (31.8-41.1)

Good34.4 (31.9-37.1)36.5 (33.2-40.0)30.9 (26.6-35.5)

Fair18.0 (15.7-20.5)21.4 (18.9-24.2)12.1 (8.9-16.2)

Poor6.5 (5.0-8.4)8.3 (6.4-10.7)3.5 (2.0-6.3)
Number of comorbidities, % (95% CI).02

08.3 (6.8-10.0)7.4 (5.7-9.5)9.8 (7.1-13.4)

1-249.4 (46.4-52.4)47.1 (43.8-50.4)53.3 (47.7-58.9)

3-842.3 (39.4-45.3)45.5 (42.5-48.6)36.8 (32.1-41.9)
Number of ADLd limitations, % (95% CI)<.001

066.4 (63.0-69.7)61.7 (58.3-64.9)74.5 (69.6-78.8)

1-222.6 (20.3-25.2)24.2 (21.2-27.4)20.0 (16.5-24.1)

3-610.0 (9.1-13.1)14.2 (11.8-16.9)5.5 (3.7-7.9)
Dementia, % (95% CI)3.7 (2.8-4.8)5.6 (4.3-7.2)0.5 (0.2-0.9)<.001
Anxiety and depression score, mean (95% CI)5.7 (5.6-5.9)6.0 (5.8-6.2)5.3 (5.1-5.5)<.001
SPPB,e mean (95% CI)7.0 (6.8-7.3)6.2 (6.0-6.5)8.4 (8.1-8.7)<.001

Gait speed2.4 (2.3-2.5)2.1 (2.0-2.2)2.9 (2.8-3.0)<.001

Balance test2.4 (2.4-2.5)2.2 (2.1-2.3)2.9 (2.8-3.0)<.001

Chair test2.2 (2.1-2.3)1.9 (1.8-2.0)2.6 (2.5-2.7)<.001
Grip strength score, mean (95% CI)2.2 (2.1-2.3)2.1 (2.0-2.2)2.5 (2.4-2.7)<.001

aNational estimates based on the complex survey design.

bP values compare individuals reported any versus no use of digital health.

cPercentages represent the weighted prevalence, and they may not sum to 100 due to rounding.

dADL: activities of daily living.

eSPPB: Short Physical Performance Battery.

Prevalence of Digital Health and Everyday Technology Use: 2015-2021

The prevalence of any digital health technology use among older adults with cancer increased from 36% in 2015 to 45% in 2019 and continued increasing in 2020 and 2021, in the amid the COVID-19 pandemic, to 51% and 52%, respectively (see Figure 1). In terms of each digital health technology use behavior, the overall use tended to increase over time, from 2015 to 2021 (see Figure 1). However, the use of technology for contacting clinicians or filling prescriptions had a more dramatic increase than other 2 types of use, obtaining health information and handling insurance. The use for obtaining health information had the highest prevalence in almost all years, whereas the use for contacting clinician had the most dramatic increase (from 19% to 34%). In 2020, with the start of the COVID-19 pandemic, the prevalence of use for contacting clinicians (37%) increased very fast, becoming even higher than the use for obtaining health information (33%). Interestingly, in the following year (2021), the use for contacting clinicians dropped slightly to 34%, whereas the use for obtaining health information increased to 38%, becoming the top one use again.

In general, the proportion of older adults with cancer who used the internet increased gradually from 59% in 2015 to 69% in 2021 (see Figure 2). In terms of each everyday technology use behavior, the overall use tended to increase over time, from 2015 to 2021 (see Figure 2).

Figure 2. Change in everyday health technology use (weighted). Error bars indicate 95% CIs of the weighted percentages. Individuals who had cancer in previous rounds and were newly diagnosed with cancer in each round were included in the analyses.

Factors Associated With Any Digital Health Technology Use

Table 2 shows the results of design-based logistic regressions. Model 1 showed that variables associated with greater use of digital health were younger age, being White, having a college or higher education, and having higher income. In model 2, when adding clinical factors to the logistic regression model, the above factors remained as being statistically significant. Additionally, more comorbidities (adjusted OR 1.14, 95% CI 1.02-1.27), fewer ADL limitations (adjusted OR 0.88, 95% CI 0.78-0.99), and nondementia (adjusted OR 0.15, 95% CI 0.07-0.34) were also associated with higher use of digital health. When physical function factors were added to model 3, ADL limitation was no longer significantly associated with digital health use, whereas higher gait speed was associated with greater digital health use (adjusted OR 1.20, 95% CI 1.02-1.40) (see Multimedia Appendix 1 for results from rounds 9 and 11).

Table 2. Weighted estimates of odds ratio in logistic regression models, 2015.a
CharacteristicAny use of digital health, aORb (95% CI)

Model 1Model 2Model 3
Age (years)

65-69ReferenceReferenceReference

70-740.75 (0.48-1.18)0.73 (0.45-1.18)0.77 (0.46-1.26)

75-790.64 (0.40-1.03)0.66 (0.38-1.12)0.72 (0.41-1.28)

80-840.32 (0.20-0.52)c0.32 (0.19-0.53)0.37 (0.21-0.66)

85-890.26 (0.15-0.45)0.28 (0.16-0.49)0.33 (0.17-0.64)

≥900.12 (0.05-0.28)0.13 (0.05-0.32)0.18 (0.06-0.48)
Female1.08 (0.78-1.49)1.06 (0.75-1.49)1.04 (0.69-1.56)
Race and ethnicity

WhiteReferenceReferenceReference

Black0.53 (0.34-0.84)0.54 (0.34-0.87)0.57 (0.35-0.93)

Hispanic0.27 (0.10-0.75)0.27 (0.10-0.71)0.29 (0.12-0.70)

Other0.58 (0.21-1.66)0.62 (0.23-1.72)0.67 (0.25-1.81)
Married or partnered1.06 (0.76-1.47)1.08 (0.76-1.52)1.05 (0.74-1.49)
Education level

Less than high school0.10 (0.05-0.22)0.10 (0.05-0.22)0.11 (0.05-0.24)

High school graduate0.25 (0.18-0.34)0.24 (0.17-0.34)0.25 (0.18-0.36)

Some college0.53 (0.39-0.72)0.52 (0.38-0.71)0.55 (0.40-0.75)

College graduate or higherReferenceReferenceReference
Annual income (US $)

<15,000ReferenceReferenceReference

15,000-29,9991.40 (0.77-2.53)1.37 (0.75-2.49)1.42 (0.79-2.55)

30,000-44,9992.32 (1.13-4.74)2.25 (1.06-4.75)2.27 (1.09-4.75)

45,000-60,0002.52 (1.14-5.56)2.53 (1.13-5.68)2.52 (1.15-5.54)

>60,0003.13 (1.57-6.24)2.81 (1.35-5.87)2.80 (1.35-5.80)
Self-rated health

ExcellentN/AdReferenceReference

Very goodN/A0.83 (0.53-1.31)0.84 (0.54-1.33)

GoodN/A0.76 (0.45-1.28)0.81 (0.48-1.37)

FairN/A0.70 (0.35-1.37)0.74 (0.38-1.47)

PoorN/A0.88 (0.31-2.49)0.99 (0.34-2.91)
Number of comorbiditiesN/A1.14 (1.02-1.27)1.15 (1.04-1.27)
Number of ADLe limitationsN/A0.88 (0.78-0.99)0.93 (0.81-1.06)
DementiaN/A0.15 (0.07-0.34)0.16 (0.07-1.06)
Anxiety and depressionN/A0.96 (0.88-1.05)0.96 (0.88-1.05)
Gait speedN/AN/A1.20 (1.02-1.40)
Balance testN/AN/A1.10 (0.94-1.29)
Chair testN/AN/A0.94 (0.83-1.08)
Grip strength scoreN/AN/A0.97 (0.84-1.12)

aModels were adjusted for the complex survey design.

baOR: adjusted odds ratio.

cItalicized values mean P<.05.

dN/A: not applicable.

eADL: activities of daily living.


Principal Findings

This study, to our knowledge, is the first to examine trends in digital health technology use among older adults with cancer and identify factors associated with digital health use using nationally representative cohort data. Our study observed a sturdy growth of digital health technology use among older adults with cancer in 4 years before the COVID-19 pandemic (2015-2019) and a strong increase during 2 years of the COVID-19 pandemic (2020-2021); however, the overall prevalence of digital health technology use is relatively low (range 36%-52%) considering its substantial benefits for improved health outcomes. In addition, this study demonstrated that lower digital health use was significantly associated with socioeconomic disparities, fewer comorbidities, and lower physical function.

Recent studies have shown an increased use of digital health technology in both cancer survivors [18,29] and older adults [30]. This study identified a notable increase in the use of digital health technology in older adults with cancer from 2015 to 2021, which is aligned with the report of increased mobile technology device ownerships in older adults from 30% in 2015 to 61% in 2021 [30]. Furthermore, there was a strong increase in digital health technology use after the COVID-19 pandemic (ie, 51% in 2020 and 52% in 2021) compared with that before the pandemic (ie, 45% in 2019). The rise in digital health technology use before and after the COVID-19 pandemic corresponds with previous studies focusing on the general population of older adults [31,32].

When seeing each type of digital health technology use, obtaining health information, contacting clinicians, and filling prescriptions were found out to be the most prevalent reasons for technology use. These findings may be related to a rapid scaling up of telemedicine adoption due to the impact of the pandemic that restricted in-person communication with health care team members [33-36]. On the other hand, handling insurance was the least prevalent reason for technology use in the entire follow-up period. Prior research suggests that caregivers typically manage insurance-related issues for older adults [37-39]. Therefore, this result should be interpreted with caution, as it might not directly reflect the respondents’ personal experiences in handling insurance matters using technology.

In this study, the prevalence of digital health technology use in older adults with cancer was lower than the prevalence of everyday technology use (ie, 36%-52% vs 59%-69%). It may be understood that older adults with cancer have sufficient materials or capabilities to use everyday technology, but they are less likely to use digital health technology. One of the multiple potential factors associated with the lower use of digital health technology in older adults with cancer may be that their need for digital health technology is lower than everyday technology, or their low eHealth literacy [40], which refers to an individual’s ability to use health-related information on electronic devices [41]. Hoogland et al [40] found that older adults with cancer were less likely to be capable in seeking health-related information on the internet, although most of them who participated in the study had an active email address or wearable devices to track activities daily. Nonetheless, caution in interpreting this relationship is advisable, as reduced usage may not necessarily indicate diminished needs. Such findings may suggest the necessity of exploring perceived barriers about digital health technology use by older adults with cancer.

Socioeconomic and racial disparities in cancer survivors’ digital health technology use were seen in older adults with cancer. This study revealed that older adults with cancer who were of White race and reported higher income and education levels were more likely to use digital health technology, which is congruent with a body of literature that examined such disparities in older adults or cancer survivors in all age ranges [13,29,42,43]. In prior studies, older age was one of the most significant factors associated with low use rate of digital health technology along with lower income and education levels and being non-White race [13,29,42,43]. In this study, there was the same association of low income and education levels and being non-White race with low use rate of digital health technology among older adults with cancer. These findings may suggest that the digital divide exists in older adults with cancer. The digital divide refers to the gap between having access to technology and not having access to it [44]. The digital divide can be caused not only by technology ownerships and broadband data access but also by trust between patients and providers and confidence in using health-related technology [44,45]. Although it is unclear that closing the digital divide is directly associated with increased engagement in digital health technology use, there is a lack of knowledge regarding how to address digital divide in the innovation and development of digital health technology. The needs of older adults with cancer for digital health technologies may be better understood through further study in order to identify methods to lessen such technological disparities.

In this study, older adults with cancer with more comorbidities were more likely to use digital health technology after controlling for all other variables. Congruent with our finding, previously published literature showed more electronic communication use in the general population, including patients without cancer, with more comorbidities [13]. However, in Cho et al’s study [18], patients with and survivors of cancer’s use of electronic communication with health care providers was not significantly associated with the number of comorbidities. The inconsistent findings may be explained by the difference in age groups. Older adults with cancer experience more comorbidities, which may generate higher needs for health-related information seeking [46]. However, such inconsistency may also be interpreted by the evidence that showed cancer survivors’ decreased demands for seeking health-related information in online when they had severe comorbidities [46,47]. Further research about older cancer survivors’ various needs for health-related information that may differ by their number and types of comorbidities and their needs for technology should be conducted.

Older adults with cancer in this study who had a cognitive problem (ie, the diagnosis of dementia) and lower physical function (ie, gait speed) were less likely to use digital health technology. This finding may indicate that frailty is particularly associated with older cancer survivors’ low prevalence of digital health technology use. The concept of “frailty,” which refers to a decline in multiple physiologic systems that can result in disabilities and vulnerabilities, is emerging in oncology research and practice as the proportion of older cancer survivors increases [48,49]. Our finding may indicate the need for a unique approach to older cancer survivors who are frail or prefrail in order to adapt shifting trends in digital health technology use for cancer survivorship care.

This study has several limitations. First, from 2015 to 2021, many survey participants were lost to follow-up or died. Of the 1996 participants, 621 participants were deceased between round 5 and round 11 and 413 participants were lost to follow-up. The sample may not be representative of the general cancer survivor population due to dropout and nonresponse. However, we controlled for the nonresponse rate and weights in our analysis to reduce the bias; second, the frequency of technology use and cancer-specific information were not available in the data set. Participants who use digital health technology may have a difference in frequency and pattern of use. Third, because of the cross-sectional nature of the analysis to examine the association between potential factors and digital health technology use, we could not clarify the direction of these relationships. For example, using digital health may help improve the physical function of older cancer survivors.

Conclusions

This study described digital health or everyday technology use in older adults with cancer from 2015 to 2021 and the associated factors with the prevalence of digital health technology use in the prepandemic period. Our findings indicated that there had been a gradual increase in technology use in older adults with cancer, particularly during the COVID-19 pandemic. However, the overall prevalence of digital health technology usage remains relatively low despite its significant potential for enhancing health outcomes. Furthermore, our study highlighted that reduced digital health adoption was associated with socioeconomic inequalities, a lower number of comorbidities, and diminished physical function. As the proportion of the older population rises in cancer survivorship, such findings may imply that future developments in digital health technology should take into account the needs of older adults with cancer, including declined health status and frail health conditions, for widespread and consistent use. Future studies are required to examine the unique clinical and physical traits of older cancer survivors and approaches to integrating digital health technology into their cancer survivorship care delivery.

Acknowledgments

YC is a research fellow supported by UTHealth-CPRIT Innovation for Cancer Prevention Research Training Program Postdoctoral Fellowship (Cancer Prevention and Research Institute of Texas grant #RP210042). This work was supported by the Agency for Healthcare Research & Quality (R01HS027846, YJ) and the National Key R&D Program of China (2020YFC2008800 and 2020YFC2008801).

Disclaimer

The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Cancer Prevention and Research Institute of Texas.

Authors' Contributions

WZ proposed the research questions and conducted data cleaning, data analysis, and manuscript writing. YC proposed the research questions and was involved in the data analysis, data interpretation, and manuscript writing. YJ and SS were involved in data interpretation, manuscript writing, and proofreading.

Conflicts of Interest

None declared.

Multimedia Appendix 1

Weighted estimates of odds ratio in logistic regression models, 2019 and 2021.

DOCX File , 19 KB

  1. Statistics and graphs. National Cancer Institute Office of Cancer Survivorship. 2022.   URL: https://cancercontrol.cancer.gov/ocs/statistics#stats [accessed 2022-01-11]
  2. Trajkovic-Vidakovic M, de Graeff A, Voest EE, Teunissen SC. Symptoms tell it all: a systematic review of the value of symptom assessment to predict survival in advanced cancer patients. Crit Rev Oncol Hematol 2012;84(1):130-148. [CrossRef] [Medline]
  3. Denis F, Basch E, Septans AL, Bennouna J, Urban T, Dueck AC, et al. Two-Year survival comparing web-based symptom monitoring vs routine surveillance following treatment for lung cancer. JAMA 2019;321(3):306-307 [FREE Full text] [CrossRef] [Medline]
  4. Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. JAMA 2017;318(2):197-198 [FREE Full text] [CrossRef] [Medline]
  5. Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 2016;34(6):557-565. [CrossRef] [Medline]
  6. Børøsund E, Cvancarova M, Moore SM, Ekstedt M, Ruland CM. Comparing effects in regular practice of e-communication and Web-based self-management support among breast cancer patients: preliminary results from a randomized controlled trial. J Med Internet Res 2014;16(12):e295 [FREE Full text] [CrossRef] [Medline]
  7. van der Meij E, Anema JR, Otten RHJ, Huirne JAF, Schaafsma FG. The effect of perioperative e-health interventions on the postoperative course: a systematic review of randomised and non-randomised controlled trials. PLoS One 2016;11(7):e0158612 [FREE Full text] [CrossRef] [Medline]
  8. Berry DL, Blonquist TM, Patel RA, Halpenny B, McReynolds J. Exposure to a patient-centered, web-based intervention for managing cancer symptom and quality of life issues: impact on symptom distress. J Med Internet Res 2015;17(6):e136 [FREE Full text] [CrossRef] [Medline]
  9. Ventura F, Öhlén J, Koinberg I. An integrative review of supportive e-health programs in cancer care. Eur J Oncol Nurs 2013;17(4):498-507. [CrossRef]
  10. den Bakker CM, Schaafsma FG, Huirne JAF, Consten ECJ, Stockmann HBAC, Rodenburg CJ, et al. Cancer survivors' needs during various treatment phases after multimodal treatment for colon cancer - is there a role for eHealth? BMC Cancer 2018;18(1):1207 [FREE Full text] [CrossRef] [Medline]
  11. Breen KE, Tuman M, Bertelsen CE, Sheehan M, Wylie D, Fleischut MH, et al. Factors influencing patient preferences for telehealth cancer genetic counseling during the COVID-19 pandemic. J Oncol Pract 2022;18(4):e462-e471. [CrossRef]
  12. Anthony DL, Campos-Castillo C, Lim PS. Who isn't using patient portals and why? Evidence and implications from a national sample Of US adults. Health Aff (Millwood) 2018;37(12):1948-1954. [CrossRef] [Medline]
  13. Yang R, Zeng K, Jiang Y. Prevalence, factors, and association of electronic communication use with patient-perceived quality of care from the 2019 health information national trends survey 5-cycle 3: exploratory study. J Med Internet Res 2022;24(2):e27167 [FREE Full text] [CrossRef] [Medline]
  14. Levine DM, Lipsitz SR, Linder JA. Trends in seniors' use of digital health technology in the United States, 2011-2014. JAMA 2016;316(5):538-540. [CrossRef] [Medline]
  15. Levine DM, Lipsitz SR, Linder JA. Changes in everyday and digital health technology use among seniors in declining health. J Gerontol A Biol Sci Med Sci 2018;73(4):552-559. [CrossRef] [Medline]
  16. Lee HY, Kim J, Sharratt M. Technology use and its association with health and depressive symptoms in older cancer survivors. Qual Life Res 2018;27(2):467-477. [CrossRef] [Medline]
  17. Haase KR, Cosco T, Kervin L, Riadi I, O'Connell ME. Older adults' experiences with using technology for socialization during the COVID-19 pandemic: cross-sectional survey study. JMIR Aging 2021;4(2):e28010 [FREE Full text] [CrossRef] [Medline]
  18. Cho Y, Yang R, Gong Y, Jiang Y. Use of electronic communication with clinicians among cancer survivors: health information national trend survey in 2019 and 2020. Telemed J E Health (forthcoming) 2022. [CrossRef] [Medline]
  19. Arthur EK, Pisegna J, Oliveri JM, Aker H, Krok-Schoen JL. Older cancer survivors' perspectives and use of telehealth in their cancer survivorship care in the United States: a ResearchMatch® sample. J Geriatr Oncol 2022;13(8):1223-1229. [CrossRef] [Medline]
  20. Hall S, Sattar S, Ahmed S, Haase KR. Exploring perceptions of technology use to support self-management among older adults with cancer and multimorbidities. Semin Oncol Nurs 2021;37(6):151228. [CrossRef] [Medline]
  21. Ivankova NV, Rogers LQ, Herbey II, Martin MY, Pisu M, Pekmezi D, et al. Features that middle-aged and older cancer survivors want in web-based healthy lifestyle interventions: qualitative descriptive study. JMIR Cancer 2021;7(4):e26226 [FREE Full text] [CrossRef] [Medline]
  22. Freedman VA, Schrack J, Skehan M, Kasper JD. National health and aging trends study user guide: rounds 1-11 beta release. 2022.   URL: https://www.nhats.org/ [accessed 2023-05-03]
  23. Kasper JD, Freedman VA. National health and aging trends study (NHATS) user guide: rounds 1-9 beta release. 2020.   URL: https://www.nhats.org/ [accessed 2023-05-03]
  24. Freedman VA, Kasper JD, Cornman JC, Agree EM, Bandeen-Roche K, Mor V, et al. Validation of new measures of disability and functioning in the national health and aging trends study. J Gerontol A Biol Sci Med Sci 2011;66(9):1013-1021 [FREE Full text] [CrossRef] [Medline]
  25. Seo JG, Park SP. Validation of the generalized anxiety disorder-7 (GAD-7) and GAD-2 in patients with migraine. J Headache Pain 2015;16(1):97 [FREE Full text] [CrossRef] [Medline]
  26. Kroenke K, Spitzer RL, Williams JB. The patient health questionnaire-2: validity of a two-item depression screener. Med Care 2003;41(11):1284-1292. [CrossRef] [Medline]
  27. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994;49(2):M85-M94. [CrossRef] [Medline]
  28. Kasper JD, Freedman VA, Niefeld MR. Construction of performance-based summary measures of physical capacity in the national health and aging trends study. NHATS Technical Paper. 2012.   URL: https://www.nhats.org/ [accessed 2023-05-03]
  29. Wu QL, Street RL. Factors affecting cancer patients' electronic communication with providers: implications for COVID-19 induced transitions to telehealth. Patient Educ Couns 2020;103(12):2583-2587 [FREE Full text] [CrossRef] [Medline]
  30. Faverio M. Shear of those 65 and older who are tech users has grown in the past decade. Pew Research Center. 2022.   URL: https:/​/www.​pewresearch.org/​fact-tank/​2022/​01/​13/​share-of-those-65-and-older-who-are-tech-users-has-grown-in-the-past-decade/​ [accessed 2022-12-06]
  31. Choi NG, DiNitto DM, Marti CN, Choi BY. Telehealth use among older adults during COVID-19: associations with sociodemographic and health characteristics, technology device ownership, and technology learning. J Appl Gerontol 2022;41(3):600-609 [FREE Full text] [CrossRef] [Medline]
  32. Kung CSJ, Steptoe A. Changes in internet use patterns among older adults in England from before to after the outbreak of the COVID-19 pandemic. Sci Rep 2023;13(1):3932 [FREE Full text] [CrossRef] [Medline]
  33. Darcourt JG, Aparicio K, Dorsey PM, Ensor JE, Zsigmond EM, Wong ST, et al. Analysis of the implementation of telehealth visits for care of patients with cancer in houston during the COVID-19 pandemic. JCO Oncol Pract 2021;17(1):e36-e43. [CrossRef] [Medline]
  34. Kotsen C, Dilip D, Carter-Harris L, O'Brien M, Whitlock CW, de Leon-Sanchez S, et al. Rapid scaling up of telehealth treatment for tobacco-dependent cancer patients during the COVID-19 outbreak in New York city. Telemed J E Health 2021;27(1):20-29 [FREE Full text] [CrossRef] [Medline]
  35. Lonergan PE, Washington Iii SL, Branagan L, Gleason N, Pruthi RS, Carroll PR, et al. Rapid utilization of telehealth in a comprehensive cancer center as a response to COVID-19. J Med Internet Res 2020;22(7):e19322 [FREE Full text] [CrossRef] [Medline]
  36. Wosik J, Fudim M, Cameron B, Gellad ZF, Cho A, Phinney D, et al. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc 2020;27(6):957-962 [FREE Full text] [CrossRef] [Medline]
  37. Adashek JJ, Subbiah IM. Caring for the caregiver: a systematic review characterising the experience of caregivers of older adults with advanced cancers. ESMO Open 2020;5(5):e000862 [FREE Full text] [CrossRef] [Medline]
  38. Rajanala A, Ramirez-Zohfeld V, O'Conor R, Brown D, Lindquist LA. Conflicts experienced by caregivers of older adults with the health-care system. J Patient Exp 2020;7(6):1130-1135 [FREE Full text] [CrossRef] [Medline]
  39. Riffin C, Van Ness PH, Wolff JL, Fried T. Family and other unpaid caregivers and older adults with and without dementia and disability. J Am Geriatr Soc 2017;65(8):1821-1828 [FREE Full text] [CrossRef] [Medline]
  40. Hoogland AI, Mansfield J, Lafranchise EA, Bulls HW, Johnstone PA, Jim HS. eHealth literacy in older adults with cancer. J Geriatr Oncol 2020;11(6):1020-1022 [FREE Full text] [CrossRef] [Medline]
  41. Norman CD, Skinner HA. eHealth literacy: essential skills for consumer health in a networked world. J Med Internet Res 2006;8(2):e9 [FREE Full text] [CrossRef] [Medline]
  42. Luo J, Tong L, Crotty BH, Somai M, Taylor B, Osinski K, et al. Telemedicine adoption during the COVID-19 pandemic: gaps and inequalities. Appl Clin Inform 2021;12(4):836-844. [CrossRef] [Medline]
  43. Fareed N, Swoboda CM, Jonnalagadda P, Huerta TR. Persistent digital divide in health-related internet use among cancer survivors: findings from the health information national trends survey, 2003-2018. J Cancer Surviv 2021;15(1):87-98 [FREE Full text] [CrossRef] [Medline]
  44. Jiang S, Liu PL. Digital divide and internet health information seeking among cancer survivors: a trend analysis from 2011 to 2017. Psychooncology 2020;29(1):61-67. [CrossRef] [Medline]
  45. Saeed SA, Masters RM. Disparities in health care and the digital divide. Curr Psychiatry Rep 2021;23(9):61 [FREE Full text] [CrossRef] [Medline]
  46. Rood JAJ, van Zuuren FJ, Stam F, van der Ploeg T, Eeltink C, Verdonck-de Leeuw IM, et al. Perceived need for information among patients with a haematological malignancy: associations with information satisfaction and treatment decision-making preferences. Hematol Oncol 2015;33(2):85-98. [CrossRef] [Medline]
  47. Frydman JL, Gelfman LP, Goldstein NE, Kelley AS, Ankuda CK. The digital divide: do older adults with serious illness access telemedicine? J Gen Intern Med 2022;37(4):984-986 [FREE Full text] [CrossRef] [Medline]
  48. Jin X, Ren Y, Shao L, Guo Z, Wang C, He Y, et al. Prevalence of frailty and prediction of mortality in Chinese cancer patients using a frailty index-based clinical algorithm-a multicentre study. Cancer Med 2021;10(18):6207-6217 [FREE Full text] [CrossRef] [Medline]
  49. Ethun CG, Bilen MA, Jani AB, Maithel SK, Ogan K, Master VA. Frailty and cancer: implications for oncology surgery, medical oncology, and radiation oncology. CA Cancer J Clin 2017;67(5):362-377 [FREE Full text] [CrossRef] [Medline]


ADL: activities of daily living
NHATS: National Health and Aging Trends Study
SPPB: Short Physical Performance Battery
OR: odds ratio


Edited by A Mavragani; submitted 22.02.23; peer-reviewed by Q Wu, W Demark-Wahnefried, K Woolley; comments to author 13.03.23; revised version received 09.04.23; accepted 26.04.23; published 31.05.23

Copyright

©Weijiao Zhou, Youmin Cho, Shaomei Shang, Yun Jiang. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 31.05.2023.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.